On April 15, 2025, S&P Global officially released the Sustainability Yearbook (China Edition) 2025. China Medical System Holdings Limited (“CMS” or the “Group”) has stood out among over 1,600 Chinese companies with its outstanding performance in environmental, social, and governance (ESG) practices, marking its third consecutive year of inclusion in the Yearbook.

Source: S&P Global

CMS has been implementing the concept of sustainable development into its strategy formulation and daily operation, focusing on unmet healthcare needs to provide better treatment solutions for doctors and patients, and striving to improve the accessibility and affordability of pharmaceutical products. At the same time, the Group has been continuously optimizing its internal governance, upholding the bottom line of product responsibility, respecting and empowering employees, and actively participating in public welfare, charity, and environmental protection activities, thus promoting a virtuous cycle of corporate development and responsibility fulfillment.

?

Through persistent dedication to sustainable development, the Group’s sustainability performance has been recognized by several domestic and international authoritative institutions: The Group’s MSCI ESG rating has been maintained at “AA”; the Hong Kong Quality Assurance Agency (HKQAA) sustainability rating is in the top 10% of the industry; and the Sino-Securities Index ESG rating is “AA”.

?

In the future, CMS will continue to uphold our original intention to advance innovative drug R&D and their equitable accessibility, and work together with stakeholders to promote the healthy, harmonious and sustainable development of our enterprise, the environment and society.

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

?

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.